Search Results - "Ballesteros, M. Paloma"

  • Showing 1 - 10 results of 10
Refine Results
  1. 1

    Transferosomes as nanocarriers for drugs across the skin: Quality by design from lab to industrial scale by Fernández-García, Raquel, Lalatsa, Aikaterini, Statts, Larry, Bolás-Fernández, Francisco, Ballesteros, M. Paloma, Serrano, Dolores R.

    Published in International journal of pharmaceutics (05-01-2020)
    “…[Display omitted] Transferosomes, also known as transfersomes, are ultradeformable vesicles for transdermal applications consisting of a lipid bilayer with…”
    Get full text
    Journal Article
  2. 2

    Oral Fixed-Dose Combination Pharmaceutical Products: Industrial Manufacturing Versus Personalized 3D Printing by Fernández-García, Raquel, Prada, María, Bolás-Fernández, Francisco, Ballesteros, M. Paloma, Serrano, Dolores R.

    Published in Pharmaceutical research (01-07-2020)
    “…Fixed-dose combination (FDC) products containing at least two different active pharmaceutical ingredients are designed to treat more effectively different…”
    Get full text
    Journal Article
  3. 3
  4. 4

    Application of Accelerated Predictive Stability Studies in Extemporaneously Compounded Formulations of Chlorhexidine to Assess the Shelf Life by González-González, Olga, Ballesteros, M Paloma, Torrado, Juan J, Serrano, Dolores R

    Published in Molecules (Basel, Switzerland) (01-12-2023)
    “…Industrially fabricated medicines have a well-defined shelf life supported by rigorous studies before their approval for commercialization. However, the shelf…”
    Get full text
    Journal Article
  5. 5
  6. 6
  7. 7

    Effect of aggregation state on the toxicity of different amphotericin B preparations by Espada, Raquel, Valdespina, Suriñe, Alfonso, Carlos, Rivas, German, Ballesteros, M. Paloma, Torrado, Juan J.

    Published in International journal of pharmaceutics (01-09-2008)
    “…The aim of this work was to study the effect of aggregation of amphotericin B (AMB) in their toxicity. The aggregation of AMB depends on different formulation…”
    Get full text
    Journal Article
  8. 8

    Co-Delivery of a High Dose of Amphotericin B and Itraconazole by Means of a Dry Powder Inhaler Formulation for the Treatment of Severe Fungal Pulmonary Infections by Celi, Salomé S, Fernández-García, Raquel, Afonso-Urich, Andreina I, Ballesteros, M. Paloma, Healy, Anne Marie, Serrano, Dolores R

    Published in Pharmaceutics (01-11-2023)
    “…Over the past few decades, there has been a considerable rise in the incidence and prevalence of pulmonary fungal infections, creating a global health problem…”
    Get full text
    Journal Article
  9. 9

    Lecithin-based oil-in-water microemulsions for parenteral use: pseudoternary phase diagrams, characterization and toxicity studies by Moreno, Marco Antonio, Ballesteros, M Paloma, Frutos, Paloma

    Published in Journal of pharmaceutical sciences (01-07-2003)
    “…Pseudoternary phase diagrams have been constructed to evaluate the phase behavior of systems containing water/lecithin/polysorbate 80/isopropyl myristate at…”
    Get more information
    Journal Article
  10. 10

    Comparative pharmacokinetics and safety of a novel lyophilized amphotericin B lecithin-based oil–water microemulsion and amphotericin B deoxycholate in animal models by Brime, Begoña, Frutos, Paloma, Bringas, Pilar, Nieto, Ana, Ballesteros, M. Paloma, Frutos, Gloria

    Published in Journal of antimicrobial chemotherapy (01-07-2003)
    “…Amphotericin B (AmB) has been a most effective systemic antifungal agent, but its use is circumscribed by the dose-limiting toxicity of the conventional…”
    Get full text
    Journal Article